RxDoctor Payments Data

Curtiss Combs, MD

Family Medicine · Temecula, CANPI 1710925409

Payments from drug & device makers

$2,594in general payments, 2019–2025

Across 182 payments — averaging $14.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$656
  • AbbVie$549
  • Amgen$213
  • Pfizer$116
  • Amarin Pharma, Inc.$113
  • Dexcom, Inc.$105
  • plus $842 from 17 others

What the payments were for

  • Food & beverage$2,582100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,594 in reported general payments places this provider in the 85th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$486,336
Medicare patients
1,018
Services billed
4,345

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban273$370,884
JardianceEmpagliflozin148$189,826
OzempicSemaglutide99$152,222
XareltoRivaroxaban98$133,142
JanuviaSitagliptin Phosphate98$103,266
RybelsusSemaglutide54$101,429
FarxigaDapagliflozin Propanediol68$77,701
Spiriva RespimatTiotropium Bromide46$40,733
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$39,405
Tresiba Flextouch U-100Insulin Degludec36$33,850
Lantus SolostarInsulin Glargine,hum.Rec.Anlog207$32,687
Atorvastatin Calcium2,618$25,831
TrulicityDulaglutide21$24,684
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr27$23,998
Repatha SureclickEvolocumab16$21,227

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$116$370,884273 claims
Novo NordiskOzempic, Rybelsus$656$253,650153 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta$20$242,442209 claims
Johnson & JohnsonXarelto, Invokana$61$148,587116 claims
MerckJanuvia$18$103,26698 claims
AstraZenecaFarxiga, Breztri Aerosphere$44$86,13981 claims
GSKTrelegy Ellipta, Anoro Ellipta$55$63,40261 claims
Lilly USA, LLCTrulicity$65$24,68421 claims
NovartisEntresto$46$18,72715 claims
AbbVieSynthroid$549$6,743167 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,533 family medicine providers in California.

Other family medicine in Temecula

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →